Dow Pharmaceutical Sciences

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

857 documents for Dow Pharmaceutical Sciences

- Rockville-Based Matthews Media Group Inc. Sues Dow Pharmaceutical Sciences Inc.
Rockville-based Matthews Media Group Inc., which helps drug companies recruit participants for clinical trials, is suing Dow Pharmaceutical Sciences Inc. for more than $310,000. The complaint, filed in U.S. District Court in Greenbelt, says Dow contacted Matthews Media after it was unable to find enough participants on its own to fill two clinical trials for acne medication.
- The Daily Record (Baltimore)
- July 13, 2007
- VALEANT TO ACQUIRE DOW PHARMACEUTICAL SCIENCES FOR $285 MIL.
Valeant Pharmaceuticals International (NYSE:VRX) has signed a definitive agreement to acquire Dow Pharmaceutical Sciences, Inc., a privately held derm...
- Biotech Financial Reports
- Vol. 16 Nbr. 1, January 2009
- Medicis Announces License and Development Agreement with Dow Pharmaceutical Sciences.
Health/Medical Writers SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 26, 2002 Medicis (NYSE:MRX) today announced it signed an exclusive license and de...
- Business Wire
- September 26, 2002

- Dow Pharmaceutical Sciences, Inc. Expands Clinical Labeling Capabilities in Petaluma, California.
GMP Clinical Labeling and Worldwide Distribution for California Companies PETALUMA, Calif. -- Dow Pharmaceutical Sciences, Inc. recently announced e...
- Business Wire
- September 04, 2008
- Sodium Shale Oil Sulfonate Eligibility for Inclusion in Monograph: Over-the-Counter Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products for Human Use, etc.
...Pharmaceutical Sciences, Inc., dated November 30, 2007. 2. Supple...
- FR, April 07, 2009
- Notices
- Food and Drug Administration
- Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
... is an investigator for Graceway Pharmaceuticals. . Dr. Green is an advisor, consultant, and invest..., an investigator for Dow Pharmaceutical Sciences, Galderma Laboratories, and Stiefel Laboratories, ...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 7, July 2011
- Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International is Completed.
PETALUMA, Calif. -- Dow Pharmaceutical Sciences, the leading provider of topical formulation development services for prescription pharmaceutical prod...
- Business Wire
- January 09, 2009
- News: Pipeline
... topical steroid formulated in Dow Pharmaceutical Sciences' proprietary water-based hydrogel vehicle...
- Medical Marketing and Media
- August 24, 2009
- Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne.
... Pillai is an employee of Dow Pharmaceutical Sciences. . REFERENCES . (1.) Chen WC, Sass JO, Se...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 6, June 2011
- Dow Pharmaceutical Sciences, Inc. to Present Scientific Poster at AAPS Evaluating the Affect of Flow Rate, Tissue Thickness and Receptor Phase Type on Drug Penetration When Appied Topically to Human Dermatomed and Dermis Only Skin.
Determining the Most Important Factors for Successful in Vitro Skin Permeation Studies PETALUMA, Calif. -- Dow Pharmaceutical Sciences, Inc., the le...
- Business Wire
- October 30, 2008